Operating Lease, Right-of-Use Asset of Atea Pharmaceuticals, Inc. from 31 Mar 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Atea Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2021 to 30 Sep 2025.
  • Atea Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $789,000, a 43% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Atea Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $789,000 -$602,000 -43% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $942,000 -$596,000 -39% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $1,093,000 -$591,000 -35% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $1,243,000 -$585,000 -32% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $1,391,000 -$579,000 -29% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $1,538,000 -$573,000 -27% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $1,684,000 -$567,000 -25% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $1,828,000 -$561,000 -23% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $1,970,000 -$556,000 -22% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $2,111,000 -$575,000 -21% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $2,251,000 -$639,000 -22% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $2,389,000 +$2,228,000 +1384% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $2,526,000 +$2,299,000 +1013% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $2,686,000 +$2,393,000 +817% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $2,890,000 +$2,534,000 +712% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $161,000 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $227,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $293,000 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $356,000 31 Mar 2021 10-Q 13 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.